Lawrence R. McGee - Amgen Discovery Res, Amgen Inc

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 53 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Tables S1-S3 from AMG 925 is a Dual FLT3/CDK4 Inhibitor with the Potential to Overcome FLT3 Inhibitor Resistance in Acute Myeloid Leukemia

Cong Li, Liqin Liu,Lingming Liang, Zhen Xia,Zhihong Li, Xianghong Wang,Lawrence R. McGee,Katie Newhall,Angus Sinclair,Alexander Kamb,Dineli Wickramasinghe,Kang Dai

openalex（2023）

Cited0Views0Bibtex

Novel Series of Tunable Μor Modulators with Enhanced Brain Penetration for the Treatment of Opioid Use Disorder, Pain and Neuropsychiatric Indications

Alok Nerurkar,Thomas Nguyen,Sheldon Wang, Ulhas Bhatt,Kevin Li, Yihong Li,Pingyu Ding, Frederick J. Seidl, Martin Holan,John Lee, Tien Widjaja, Zhi-Liang Wei, Corinne Sadlowski,David Sperandio,Lawrence R. McGee,Beth Youngblood,Neil Schwartz,Donald Gehlert,Julio C. Medina

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2023)

Cited1Views0WOSBibtex

INHIBITEURS DE RÉCEPTEURS GLUCOCORTICOÏDES

Daqing Sun,Lawrence R. McGee, Xiaohui Du, Liusheng Zhu, Xuelei Yan,Yosup Rew,John Eksterowicz, Julio C. Medina, Haiying Zhou, Minna Balbas,Valeria R. Fantin

openalex（2017）

Cited0Views0Bibtex

Discovery and in Vivo Evaluation of the Potent and Selective PI3Kδ Inhibitors 2-((1S)-1-((6-amino-5-cyano-4-pyrimidinyl)amino)ethyl)-6-fluoro-n-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-0687) and 2-((1S)-1-((6-amino-5-cyano-4-pyrimidinyl)amino)ethyl)-5-fluoro-n-methyl-3-(2-pyridinyl)-4-quinolinecarboxamide (AM-1430)

JOURNAL OF MEDICINAL CHEMISTRY（2016）

Cited19Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn